GlobeNewswire by notified

Terranet's associated company holoride GmbH is expanding its market roll-out and has secured a convertible loan for this purpose

Share

Terranet has, together with the other shareholders of holoride GmbH, entered into a financing agreement to accelerate a broader and more intensive launch of holoride's products in additional markets.

Terranet's share in holoride is 10.4%. At the end of last year, holoride launched its unique and award-winning XR/VR product for integration into vehicles manufactured by Audi. At the beginning of the current year, a retrofit version was launched, which opens up for a significantly larger market as the new version can easily be retrofitted directly by the end consumer in all vehicles regardless of manufacturer and model. The launch was made during CES in Las Vegas and holoride received the CES Innovation Awards Honoree.

The financing agreement enables an intensive market roll-out and broadening of Holoride's products through the issuance of a convertible loan by one of the shareholders (not Terranet) to holoride of MEUR 5. In addition to the German market, Holoride has so far been launched in the US and Austria and is now ready for additional European countries. At the same time, the user opportunity is broadened as holoride will be integrated into several other vehicle manufacturers' models. Holoride's technology is also expected to be integrated into devices of well-known consumer-oriented companies and, conversely, it is planned to make popular digital mainstream services available on the holoride platform.

Through the debt financing, Terranet can avoid a dilution and holoride receives a quick opportunity to accelerate its launch. Terranet then has an opportunity to, together with the other shareholders or external investors, refinance the convertible loan for holoride before October 1, 2023. If the convertible loan is not refinanced by this date, the lender has an option to acquire all shares in holoride within six months at a market valuation.

For more information, please contact
Magnus Andersson, CEO
E-mail: magnus.andersson@terranet.se

About Terranet AB (publ)

Terranet is on a mission to save lives in urban traffic.

We develop breakthrough tech solutions for Advanced Driver Assistance Systems (ADAS) and Autonomous Vehicles (AV) that protect vulnerable road users.

With a unique patented vision technology, Terranet’s anti-collision system BlincVision laser scans and detects road objects up to ten times faster and with higher accuracy than any other ADAS technology available today. 

Terranet is based in Lund, Sweden, and in the heart of the European automotive industry in Stuttgart, Germany. The company is listed on Nasdaq First North Premier Growth Market since 2017(Nasdaq: TERRNT-B). 

Follow our journey at www.terranet.se

Certified Adviser to Terranet is Mangold Fondkommission AB, 08-503 015 50, ca@mangold.se.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Første uge i tilbudsperioden i Jobindex A/S10.6.2023 12:00:37 CEST | pressemeddelelse

Danielsen 2 aps - der er hovedaktionær i Jobindex A/S - har den 2. juni 2023 fremsat et frivilligt ureguleret offentligt købstilbud om at købe aktier i Jobindex A/S til en pris på 1900 kr. pr. aktie i forbindelse med ansøgning om afnotering fra First North. På tilbudsperiodens tredje og fjerde dag har Danielsen 2 aps købt 1212 og 944 aktier á 1900 kr. pr. aktie. Den første uge har Danielsen 2 aps i alt købt 4645 aktier. Tilbudsperioden fortsætter indtil den 30. juni 2023. Det forventes at Jobindex A/S derefter vil blive afnoteret og slettet fra handel på Nasdaq First North i henhold til punkt 2.6(c)(i) i Supplement D i Nasdaqs regler. Yderligere oplysninger Direktør Kaare Danielsen, telefon 20735010, email kd@jobindex.dk Certified Adviser Jakob Tolstrup Kristensen, email jakob.tolstrup@cwicf.com Vedhæftet fil Aktiehandel tilbud 2023 juni 9

PRIX FITZGERALD 2023 LAUREATE ANNOUNCED AT HÔTEL BELLES RIVES10.6.2023 01:03:24 CEST | Press release

Quentin Tarantino Accepts 12th Annual Literary Award for Cinema Speculation CAP D’ANTIBES, France, June 09, 2023 (GLOBE NEWSWIRE) -- During an unforgettable ceremony held this evening Hôtel Belles Rives in Juan-les-Pins on the French Riviera, jury members of the 2023 Prix Fitzgerald, a French literary award created in 2011 by Marianne Estène-Chauvin, President of the Francis Scott Fitzgerald Academy and owner of Belles Rives Group, announced today this year’s laureate. The long-awaited first work of nonfiction from the author of the #1 New York Times bestselling Once Upon a Time in Hollywood, Quentin Tarantino accepted the prize for Cinema Speculation, published by HarperCollins in the United States and Weidenfeld & Nicolson in the United Kingdom on November 1, 2022 and French publishing house, Flammarion on March 22, 2023. Every year in June, the Hôtel Belles Rives hosts the Prix Fitzgerald, which honors a novel or short story that reflects the elegance, spirit, and art of living embo

FDA Advisory Committee Votes Unanimously to Confirm the Clinical Benefit of LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer’s Disease10.6.2023 00:45:00 CEST | Press release

Peripheral and Central Nervous System Drugs Advisory Committee votedbased on data from large global confirmatory Phase 3 Clarity AD clinical trial in patients living with early Alzheimer’s disease The PDUFA action date for traditional approval of LEQEMBI has been set for July 6, 2023, with designation of priority review LEQEMBI received accelerated approval from the FDA for the treatment of early Alzheimer’s disease on January 6, 2023 TOKYO and CAMBRIDGE, Mass., June 09, 2023 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) voted unanimously that the data from Eisai’s Phase 3 Clarity AD clinical trial confirms the clinical benefit of LEQEMBI® (lecanemab-irmb) 100 mg/mL injection for intravenous

Travel Startup Yovivo Expands Core Team With New Staff Members9.6.2023 20:47:00 CEST | Press release

Extended stays booking site hires Karen Kochmann (Ex-Expedia) and Erik Beekman (Ex Savills) to keep up with its fast expansion ROTTERDAM, Netherlands, June 09, 2023 (GLOBE NEWSWIRE) -- Growing startup Yovivo.com today announced its latest team expansion with the addition of two key members from the travel and real estate industries. Karen Kochmann has been taken on by Yovivo in the position of Strategic Growth Manager. Formerly Expedia’s Account Manager for the Balearic Islands (where the Yovivo offices and team are located), Karen boasts over seven years of experience, a masters degree in Digital Marketing and E-commerce, and a Banking degree from Lauder Business School. “I plan to developing strategic partnerships which will help Yovivo grow and position itself as a leading brand for extended stays. With my experience in the field of tech and tourism I will be able to bring fresh ideas to both the development of the platform and the B2C and B2B approach planned. I'll also focus on cr

Nokia Corporation: Repurchase of own shares on 09.06.20239.6.2023 20:00:00 CEST | Press release

Nokia Corporation Stock Exchange Release 9 June 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 09.06.2023 Espoo, Finland – On 9 June 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL323,9103.77CEUX33,5313.77AQEU1,0683.77TQEX14,9913.77Total373,5003.77 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 5 April 2022 started on 2 January 2023 and e